Skip to Main Content

Paper Details

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.
Science
145
2021
Author NameAffiliation
Bjoern MeyerInstitut Pasteur
Marco VignuzziArgonne National Laboratory
Marco VignuzziInstitut Pasteur
Nicholas S HeatonInstitut Pasteur
Nicholas S HeatonDuke University
Andrzej JoachimiakDuke University
Andrzej JoachimiakCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign
Andrzej JoachimiakCenter for Structural Genomics of Infectious Diseases, University of Chicago
Andrzej JoachimiakArgonne National Laboratory
Andrzej JoachimiakThe University of Chicago
  • 1 - 10

Datasets

Release 1.2